Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05482607

Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease

Unsupervised Clustering Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Systemic sclerosis (SSc) is a heterogeneous systemic autoimmune disease with distinct prognosis according to patients. Interstitial lung disease (ILD) concerns almost 50 % of SSc patients and represents the main cause of mortality. SSc-ILD is variable: from limited forms (with asymptomatic patients) to extensive lesions. Disease course in SSc-ILD is also highly variable: patients can experience stable disease, slow or fast progression. Investigators performed unsupervised clustering analysis to classify SSc-ILD according to elementary radiological lesions on HRCT scan.

Conditions

Timeline

Start date
2023-01-01
Primary completion
2025-10-01
Completion
2025-10-01
First posted
2022-08-01
Last updated
2024-08-27

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05482607. Inclusion in this directory is not an endorsement.

Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease (NCT05482607) · Clinical Trials Directory